{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Saint Paul",
      "address_1": "4100 Hamline Ave N Bldg 3",
      "reason_for_recall": "Boston Scientific has identified a subset of   active pacemaker and CRT-Ps systems with an  elevated potential for early pacemaker replacement due to hydrogen-induced accelerated battery depletion.",
      "address_2": "",
      "product_quantity": "",
      "code_info": "VISIONIST X4 (CRT-P) model U228",
      "center_classification_date": "20180927",
      "distribution_pattern": "AK, AL, AR, AZ, CA, CO,  CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY,  LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY,  OH, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, W A, WI, WV, and WY",
      "state": "MN",
      "product_description": "VISIONIST  X4 CRT-P (Cardiac Resynchronization Therapy Pacemaker)",
      "report_date": "20181003",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Boston Scientific Corporation",
      "recall_number": "Z-3259-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "81001",
      "termination_date": "20191104",
      "more_code_info": "",
      "recall_initiation_date": "20180910",
      "postal_code": "55112-5700",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}